FundComb

Investment & M&A transaction comps

probiotics Investment & M&A Transaction Comps

Explore investment and M&A transactions tagged probiotics. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.

Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.

Explore 5 transactions ↓ Browse all comp sectors →
Reviewed transactions
5
With value data
2
With revenue multiples
3
Transaction years
2017–2026

Sortable transaction comps

probiotics transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

2 / 5

Acquisition EV, USD

USD 368M

Investment EV, USD

-

Median EV / revenue

5.6x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

5 shown of 5 matching transactions. Click any transaction row for more detail.

Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.

Select for comparison
2026-07-31 Lallemand Inc. Undisclosed - -
Dietary SupplementsEnzymes
+4
ProbioticsHealth IngredientsHealthcareMicrobial Ingredients
Bucklebury
Control
 2022-09-01 Haleon Undisclosed - -
ProbioticsCPG
+1
Probiotic Manufacturing
Microbiome Labs
Control
 2021-01-06 Novozymes 125 3.1x 6.0x
ProbioticsCPG
+2
Microbiome SupplementsProbiotics / Microbiome Supplements
2018-07-02 ADM 243 5.6x 21.2x
Animal HealthConsumer
+7
CPGDietary SupplementsProbioticsMicrobiomeNutraceuticalsProbiotic ProductsWellness
Ganeden
Control
 2017-10-11 Kerry Group Undisclosed 6.0x 20.0x
ProbioticsConsumer
+2
IngredientsProbiotics Ingredients

Explore related tags

Continue to the full transaction history for each tag.

CPG 3Consumer 2dietary supplements 2animal health 1enzymes 1health ingredients 1Healthcare 1ingredients 1microbial ingredients 1microbiome 1

Explore buyers & investors

ADM 1Haleon 1Kerry Group 1Lallemand Inc. 1Novozymes 1

Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.

Values may be estimated, rumored, incomplete or derived from public information. Transaction comps are informational and should not be relied on as financial, investment or valuation advice.